Austar Lifesciences Limited (6118.HK)

HKD 0.79

(0.0%)

Net Income Summary of Austar Lifesciences Limited

Austar Lifesciences Limited's latest annual net income in 2023 was -113.47 Million CNY , down -229.74% from previous year.
Austar Lifesciences Limited's latest quarterly net income in 2024 Q2 was 5.87 Million CNY , down 0.0% from previous quarter.
Austar Lifesciences Limited reported an annual net income of 87.46 Million CNY in 2022, down -68.46% from previous year.
Austar Lifesciences Limited reported an annual net income of 277.3 Million CNY in 2021, up 737.76% from previous year.
Austar Lifesciences Limited reported a quarterly net income of -113.47 Million CNY for 2023 FY, down -229.74% from previous quarter.
Austar Lifesciences Limited reported a quarterly net income of -39.94 Million CNY for 2023 Q2, down -195.98% from previous quarter.

Annual Net Income Chart of Austar Lifesciences Limited (2023 - 2013)

Historical Annual Net Income of Austar Lifesciences Limited (2023 - 2013)

Year	Net Income	Net Income Growth
2023	-113.47 Million CNY	-229.74%
2022	87.46 Million CNY	-68.46%
2021	277.3 Million CNY	737.76%
2020	33.1 Million CNY	309.1%
2019	8.09 Million CNY	7461.68%
2018	107 Thousand CNY	100.2%
2017	-54.08 Million CNY	-189.69%
2016	-18.67 Million CNY	-392.45%
2015	6.38 Million CNY	-90.21%
2014	65.19 Million CNY	21.69%
2013	53.57 Million CNY	0.0%

Year	Net Income	Net Income Growth
2024 Q2	5.87 Million CNY	0.0%
2023 FY	-113.47 Million CNY	-229.74%
2023 Q2	-39.94 Million CNY	-195.98%
2022 Q2	45.84 Million CNY	-22.86%
2022 Q4	41.61 Million CNY	-9.22%
2022 FY	87.46 Million CNY	-68.46%
2021 Q2	217.87 Million CNY	972.3%
2021 FY	277.3 Million CNY	737.76%
2021 Q4	59.43 Million CNY	-72.72%
2020 Q4	20.31 Million CNY	58.96%
2020 Q2	12.78 Million CNY	225.91%
2020 FY	33.1 Million CNY	309.1%
2019 Q2	4.16 Million CNY	8.79%
2019 FY	8.09 Million CNY	7461.68%
2019 Q4	3.92 Million CNY	-5.92%
2018 Q2	-3.72 Million CNY	87.15%
2018 Q4	3.83 Million CNY	202.87%
2018 FY	107 Thousand CNY	100.2%
2017 FY	-54.08 Million CNY	-189.69%
2017 Q4	-28.98 Million CNY	-15.5%
2017 Q2	-25.09 Million CNY	-283.51%
2016 FY	-18.67 Million CNY	-392.45%
2016 Q2	-12.12 Million CNY	-222.41%
2016 Q4	-6.54 Million CNY	46.03%
2015 FY	6.38 Million CNY	-90.21%
2015 Q4	-3.76 Million CNY	-137.07%
2015 Q2	10.14 Million CNY	-68.73%
2014 FY	65.19 Million CNY	21.69%
2014 Q4	32.44 Million CNY	-0.94%
2014 Q2	32.75 Million CNY	82.37%
2013 Q2	35.61 Million CNY	165.91%
2013 Q4	17.95 Million CNY	-49.57%
2013 FY	53.57 Million CNY	0.0%
2012 Q4	13.39 Million CNY	0.0%

Peer Net Income Comparison of Austar Lifesciences Limited

Name	Net Income	Net Income Difference
Vincent Medical Holdings Limited	57.27 Million HKD	298.12%